News on Actos

Drugmakers angle for advantage in treating diabetes

2011-06-29T09:00:12Z

SAN DIEGO (Reuters) - Obesity and longevity have helped make diabetes an epidemic in much of the world, and drugmakers are jockeying to make sure their medicines are used early and often.

Companies including Sanofi and Actos, a medicine that treats adult onset diabetes, also prevented the development of the disease in more than 70 percent of people who are considered high risk, according to findings announced Wednesday.

The results could help tens of millions of pre-diabetics in the world, including 40 million Americans, who are considered high risk because of excessive weight, ethnicity or other predispositions.

An Actos (pioglitazone) pill taken e...

Side effects of Actos

2010-11-29T15:21:00Z

...

Actos Coupons

2010-11-30T12:52:31Z

...

Diabetes Management without Medications

2010-11-03T09:40:16Z

...

Finding helpful diabetic supply

2010-11-02T21:38:36Z

...

US Agency Probes Risks Of Bladder Cancer With Diabetes Pill Actos, Rival To Glaxo's Avandia

2010-11-02T12:40:18Z

...

FDA Drug Safety Communication: Ongoing Safety Review of Actos (pioglitazone) and Potential Increased Risk of Bladder Cancer After Two Years Exposure

2010-09-21T14:00:02Z

...

Avandia: Less Risky in Younger, Healthier Patients?

2010-09-11T13:58:34Z

...

New Data Supports Link Between Diabetes Drugs, Fractures

2010-09-10T20:14:45Z

...

Diabetics Urged to Confer With Their Doctor About Avandia Use

2010-09-10T20:11:28Z

...

Study raises hope for safer diabetes drugs

2010-07-21T15:30:50Z

CHICAGO (Reuters) - A new understanding of the link between diabetes and obesity may help drug companies design safer versions of treatments like GlaxoSmithKline's Avandia, U.S. researchers said on Wednesda...

InteKrin Therapeutics Presented Phase 2b Clinical Data at the 2010 American Diabetes Association Annual Meeting, Demonstrating Improved Glycemic Control in Patients with Type 2 Diabetes Without Causing the Edema Seen with Pioglitazone

2010-11-02T12:39:21Z

...

DURATION-4 Study Results Released

2010-10-27T09:04:19Z

...

DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment

2010-10-27T09:04:16Z

...

Half doses of diabetes drugs can prevent disease

2010-06-02T15:45:41Z

WASHINGTON (Reuters) - Low doses of GlaxoSmithKline's diabetes drug Avandia combined with metformin can prevent diabetes without causing the most common side-effects, Canadian doctors reported on Wednesday.

Taking half a dose of Glaxo's combination pill reduced by two-thirds the risk that patients would...

Vitamin E shows promise for treating liver disease

2010-04-28T14:15:54Z

Doctors: Vitamin E shows promise for treating obesity-related fatty liver disease

People with a common, obesity-related liver disease that has no known treatment got a surprising benefit from vitamin E pills, researchers reported Wednesday.

It appears to be the first time that a vitamin supplement has been shown to help treat a major ailment not caused by a nutrient deficiency. However, doctors warned that this does not mean people should automatically take ...

Pfizer Gains Presence in Diabetes Market with Takeda Deal

2010-10-22T13:02:00Z

...

Comparison Between Metformin and Other Diabetes Medications

2010-10-22T13:24:36Z

...

Diabetes Drugs Go Head-to-Head in Study

2010-10-24T09:53:03Z

...

pioglitazone

2010-10-26T23:30:01Z

...

Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and Actos (pioglitazone HCl) for the Treatment of Type 2 Diabetes

2010-10-24T09:16:21Z

...

SYR-322/Actos

2010-10-24T09:15:31Z

...

InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting

2010-10-24T09:14:54Z

...

New Diabetes Drug Shows Promise in Trial

2010-10-24T09:14:52Z

...

Diabetes Roundup: Drugs, Stents and Stocks

2010-10-24T09:56:26Z

...

Halting Avandia Use Hikes Blood Sugar Levels

2010-10-26T20:24:25Z

...

Some diabetes drugs linked to eye disorder

2010-10-26T21:03:02Z

...

2 Diabetes Drugs Double Fracture Risk in Women

2010-10-23T19:05:05Z

...

Trial Results Don't Look Good for GlaxoSmithKline's Diabetes Drug

2010-10-21T09:13:18Z

...

Why Avandia and Actos Carry New Safety Warnings

2010-10-26T12:00:28Z

...

Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.

2010-10-23T16:01:26Z

...

Actos May Help Prevent Type 2 Diabetes

2010-10-23T09:53:53Z

...

Diabetes Medication = Broken Bones?

2010-10-26T12:11:37Z

...

New Worries Over Blockbuster Meds Avandia, Fosamax

2010-10-26T12:11:36Z

...

New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with Actos (pioglitazone HCl)

2010-10-23T09:20:18Z

...

Diabetes Drug Slows Clogging of Arteries

2010-10-23T09:56:13Z

...

Older Diabetics Using Avandia Face Increased Death Risk

2010-10-22T22:59:40Z

...

Takeda marketing campaign will tout safety of Actos just as Glaxo adds new warnings to Avandia

2010-09-10T11:22:44Z

Takeda Pharmaceuticals will roll out advertisements touting the safety of its diabetes drug Actos just two days after rival GlaxoSmithKline said it would beef up warnings about heart attack risks associated with its own diabetes pill, Avandia...

Diabetes drug Actos offers some heart benefits, but try older drugs first, report says

2010-09-09T22:21:38Z

The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows.

However, the Japanese-made Actos also carries an increased risk of nonfatal heart failure, the analysis showed, confirming earlier studies. Heart failure is also a side effect with Avandia. Such problems led one diabetes expe...

Analysis weighs benefits, risks of Actos

2010-09-09T20:19:43Z

Analysis Shows That Diabetes Pill Actos Cuts Odds of Stroke, but Boosts Risk of Heart Failure

The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it also carries an increased risk of nonfatal heart failure, the analysis showed, confirming earlier stu...

Diabetes drugs to include new warnings

2010-09-09T14:52:20Z

Diabetes Drugs Avandia and Actos to Include New Heart Failure Warnings

The diabetes drugs Avandia and Actos will be labeled with severe warnings about a risk of heart failure to some patients, health officials said Tuesday.

The makers of the drugs, GlaxoSmithKline Plc and Avandia and Actos will be labeled with severe warnings about a risk of heart failure to some patients, health officials said Tuesday.

The makers of the drugs, GlaxoSmithKline Plc and Takeda Pharmaceutical Company Ltd....

Merck, Amilyn Should Profit From Avandia's and Actos' Problems

2010-10-15T09:27:58Z

...

Study: Older diabetes drugs safe to use

2010-09-09T09:33:28Z

Analysis Finds That Older, Cheaper Diabetes Drugs Are As Safe, Effective As New Pills

Older, cheaper diabetes drugs are as safe and effective as newer ones, concludes an analysis that is good news for diabetics and may further hurt sales of Avandia, a blockbuster pill recently tied to heart problems.

The clear winner: metformin, sold as Glucophage and genericall...